This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schneider, C. et al. Nat. Biotechnol. 30, 744–746 (2012).
Schellekens, H. & Moors, E. Nat. Biotechnol. 28, 28–31 (2010).
European Medicine Agency. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues EMEA/CHMP/BWP/49348/2005 (2006). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003953.pdf
European Medicine Agency. Withdrawal assessment report Marvel insulin (2010). http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500067086.pdf
European Medicines Agency. European public assessment report (EPAR) for Alpheon (2007). http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/000585/WC500017451.pdf
Hermeling, S., Jiskoot, W., Crommelin, D., Bornaes, C. & Schellekens, H. Pharm. Res. 22, 847–851 (2005).
Prümmer, O. Biotherapy 10, 15–24 (1997).
Baumann, A. . Curr. Drug Metab. 7, 15–21 (2006).
Mahmood, I. & Green, M.D. Clin. Pharmacokinet. 44, 331–347 (2005).
European Medicine Agency. European public assessment report Avonex (2006). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000102/WC500029420.pdf
Alam, J. et al. Pharm. Res. 14, 546–549 (1997).
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Schneider, C., Borg, J., Ehmann, F. et al. Reply to In support of the European Union biosimilar framework. Nat Biotechnol 30, 748–749 (2012). https://doi.org/10.1038/nbt.2327
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2327
This article is cited by
-
Setting the stage for biosimilar monoclonal antibodies
Nature Biotechnology (2012)